Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000809001 | SCV000949135 | likely benign | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000809001 | SCV003831805 | uncertain significance | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | 2020-06-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258985 | SCV003981924 | uncertain significance | Inborn genetic diseases | 2023-05-17 | criteria provided, single submitter | clinical testing | The c.404G>A (p.R135Q) alteration is located in exon 6 (coding exon 5) of the DNAJB6 gene. This alteration results from a G to A substitution at nucleotide position 404, causing the arginine (R) at amino acid position 135 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |